Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] - N0000175823

Pharmacologic Class Information

Pharmacologic Code N0000175823
Pharmacologic Name Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
Pharmacologic Uses
  • hydrolytic lysozomal glycosaminoglycan (GAG)-specific enzyme
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
54092-700Elaprase Non-Proprietary Name: IdursulfaseSolution, ConcentrateIntravenousTakeda Pharmaceuticals America, Inc.ACTIVE
58468-0070Aldurazyme Non-Proprietary Name: LaronidaseInjection, Solution, ConcentrateIntravenousGenzyme CorporationACTIVE
68135-020 Non-Proprietary Name: GalsulfaseSolutionBiomarin Pharmaceutical Inc.ACTIVE
68135-020Naglazyme Non-Proprietary Name: GalsulfaseSolutionIntravenousBiomarin Pharmaceutical Inc.ACTIVE
68135-100 Non-Proprietary Name: Elosulfase AlfaInjection, Solution, ConcentrateBiomarin Pharmaceutical Inc.ACTIVE
68135-100Vimizim Non-Proprietary Name: Elosulfase AlfaInjection, Solution, ConcentrateIntravenousBiomarin Pharmaceutical Inc.ACTIVE